Skip to NavigationSkip to content

News

0
Novartis’ IL-17A inhibitor has chalked up approval from the European Commission (EC) for the treatment of patients between the ages of six and 18...
0
The EU has reached an agreement with Sanofi for 300 million doses of their COVID-19 vaccine candidate which will allow the trading bloc’s members to...
0
Two new coronavirus tests are set to be made available throughout England that are significantly faster than most already in use.
0
The FDA has awarded MorphoSys and Incyte US approval for their Fc-modified cytolytic CD19-targeting monoclonal antibody Monjuvi (tafasitamab-cxix),...

Features

CAR T cell therapy, while a revolutionary and life-saving technology, is extremely expensive and is not guaranteed to work, meaning that American...